Literature DB >> 25811427

In Vivo Transfection and Detection of Gene Expression of Stem Cells Preloaded with DNA-carrying Microbubbles.

Sidhartha Tavri1, Alexander Vezeridis1, Wenjin Cui1, Robert F Mattrey1.   

Abstract

PURPOSE: To determine whether (a) stem cells loaded with DNA-carrying microbubbles (MBs) can be transfected in vivo, (b) the cells remain alive to express the gene, and (c) gene expression is sufficiently robust to be detected in vivo.
MATERIALS AND METHODS: The study was approved by the Institutional Animal Care and Use Committee. Cationic MBs were prepared, characterized, and loaded with pLuciferase green fluorescent protein (GFP) plasmid. Loading was confirmed with SYBR Gold staining (Life Technologies, Carlsbad, Calif). C17.2 cells were loaded with the DNA-carrying MBs. Two hundred thousand cells suspended in 20 μL phosphate-buffered saline were mixed with 200 μL Matrigel (BD Biosciences, San Jose, Calif) and injected in both flanks of eight nude mice. One of the Matrigel (BD Biosciences) injections contained 50 000 cells pretransfected in vitro by using lipofectamine as a positive control. Nine flanks were exposed to 2.25-MHz ultrasonic pulses at 50% duty cycle for 1 minute at 1 W/cm(2) (n = 3) or 2 W/cm(2) (n = 6), and six flanks served as the negative control. Two days later, bioluminescent images were acquired in each mouse every 3 minutes for 1 hour after the intraperitoneal injection of d-luciferin (Perkin Elmer, Waltham, Mass). Differences between groups were assessed by using the nonparametric Kruskal-Wallis test with Wilcoxon rank sum tests for follow-up comparisons. Mice were then killed, plugs were explanted, and alternate sections were stained with hematoxylin-eosin or stained for GFP expression.
RESULTS: Mean DNA-loaded MB diameter ± standard deviation was 2.87 μm ± 1.69 with the DNA associated with the MB shell. C17.2 cells were associated with 2-4 MBs each, and more than 90% were viable. Peak background subtracted bioluminescent signal was fourfold higher when cells were exposed to 2 W/cm(2) pulses as compared with 1 W/cm(2) pulses (P = .02) and negative controls (P = .002). Histologic examination showed cells within the Matrigel (BD Biosciences) with robust GFP expression only after 2 W/cm(2) ultrasound exposure and lipofectamine transfection.
CONCLUSION: Stem cells loaded with DNA-carrying MBs can be transfected in vivo with ultrasonic pulses and remain alive to demonstrate robust gene expression. (©) RSNA, 2015

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25811427      PMCID: PMC4521611          DOI: 10.1148/radiol.15141380

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  24 in total

1.  Optical and acoustical dynamics of microbubble contrast agents inside neutrophils.

Authors:  P A Dayton; J E Chomas; A F Lum; J S Allen; J R Lindner; S I Simon; K W Ferrara
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

Review 2.  Physical principles of microbubbles for ultrasound imaging and therapy.

Authors:  Eleanor Stride
Journal:  Cerebrovasc Dis       Date:  2009-04-16       Impact factor: 2.762

3.  Transfection efficiency of TDL compound in HUVEC enhanced by ultrasound-targeted microbubble destruction.

Authors:  Jian-Li Ren; Zhi-Gang Wang; Yong Zhang; Yuan-Yi Zheng; Xing-Sheng Li; Qun-Xia Zhang; Zhao-Xia Wang; Chuan-Shan Xu
Journal:  Ultrasound Med Biol       Date:  2008-06-04       Impact factor: 2.998

Review 4.  DNA-based therapeutics and DNA delivery systems: a comprehensive review.

Authors:  Siddhesh D Patil; David G Rhodes; Diane J Burgess
Journal:  AAPS J       Date:  2005-04-08       Impact factor: 4.009

5.  Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles.

Authors:  J R Lindner; P A Dayton; M P Coggins; K Ley; J Song; K Ferrara; S Kaul
Journal:  Circulation       Date:  2000-08-01       Impact factor: 29.690

6.  Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage.

Authors:  Q L Lu; H-D Liang; T Partridge; M J K Blomley
Journal:  Gene Ther       Date:  2003-03       Impact factor: 5.250

7.  Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model.

Authors:  K Nakamura; Y Ito; Y Kawano; K Kurozumi; M Kobune; H Tsuda; A Bizen; O Honmou; Y Niitsu; H Hamada
Journal:  Gene Ther       Date:  2004-07       Impact factor: 5.250

8.  Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model.

Authors:  C Ren; S Kumar; D Chanda; L Kallman; J Chen; J D Mountz; S Ponnazhagan
Journal:  Gene Ther       Date:  2008-07-03       Impact factor: 5.250

9.  Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.

Authors:  Michael R Loebinger; Ayad Eddaoudi; Derek Davies; Sam M Janes
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

10.  Ultrasound-targeted microbubble destruction-mediated gene delivery into canine livers.

Authors:  Misty L Noble; Christian S Kuhr; Scott S Graves; Keith R Loeb; Samuel S Sun; George W Keilman; Kyle P Morrison; Marla Paun; Rainer F Storb; Carol H Miao
Journal:  Mol Ther       Date:  2013-06-04       Impact factor: 11.454

View more
  4 in total

Review 1.  Advances in Stimulus-Responsive Polymeric Materials for Systemic Delivery of Nucleic Acids.

Authors:  Minjie Sun; Kaikai Wang; David Oupický
Journal:  Adv Healthc Mater       Date:  2017-12-11       Impact factor: 9.933

2.  Assessment of endothelial colony forming cells delivery routes in a murine model of critical limb threatening ischemia using an optimized cell tracking approach.

Authors:  Marta Rojas-Torres; Ismael Sánchez-Gomar; Antonio Rosal-Vela; Lucía Beltrán-Camacho; Sara Eslava-Alcón; José Ángel Alonso-Piñeiro; Javier Martín-Ramírez; Rafael Moreno-Luna; Mª Carmen Durán-Ruiz
Journal:  Stem Cell Res Ther       Date:  2022-06-21       Impact factor: 8.079

Review 3.  Monitoring/Imaging and Regenerative Agents for Enhancing Tissue Engineering Characterization and Therapies.

Authors:  Daniela Y Santiesteban; Kelsey Kubelick; Kabir S Dhada; Diego Dumani; Laura Suggs; Stanislav Emelianov
Journal:  Ann Biomed Eng       Date:  2015-12-21       Impact factor: 4.219

4.  Antibody production by in vivo RNA transfection.

Authors:  Bizhan Romani; Amirarsalan Kavyanifard; Elham Allahbakhshi
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.